Stamford, Connecticut--(Newsfile Corp. - November 12, 2020) - As required by applicable securities laws, NGN BioMed Opportunity II, L.P. ("NGN") announces that, as a result of the completion of a recent private placement of common shares by Zenith Capital Corp. ("Company"), NGN holds less than 10% of the issued and outstanding common shares of the...